Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment strategy for recurrent vasovagal syncope
NL-OMON28970Recruiting
- Sponsor
- Academic Medical Center
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of midodrine in Neurocardiogenic syncope (NCS) (3 arms), sponsored by Academic Medical Center. Primary endpoint: Total burden of syncope recurrence. Started Jan 2005; status: recruiting.
02
Drugs
midodrine
03
Conditions
Neurocardiogenic syncope (NCS)
Beyond the preview
Go deeper on NL-OMON28970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28970.